Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
FBTA-05 by Lindis Biotech for Non-Hodgkin Lymphoma: Likelihood of Approval
FBTA-05 is under clinical development by Lindis Biotech and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase...
Data Insights
FBTA-05 by Lindis Biotech for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
FBTA-05 is under clinical development by Lindis Biotech and currently in Phase I for Chronic Lymphocytic Leukemia (CLL). According to...